Jpmorgan Chase & CO Zymergen Inc. Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.2 - $3.37 $2.05 Million - $5.75 Million	-1,705,955 Reduced 73.46%	616,473 $1.71 Million
Q2 2022 Aug 11, 2022	SELL	$1.12 - $3.03 $2.07 Million - $5.6 Million	-1,847,595 Reduced 44.31%	2,322,428 $2.86 Million
Q1 2022 May 11, 2022	BUY	$2.88 - $7.02 $1.75 Million - $4.26 Million	606,588 Added 17.02%	4,170,023 $12.1 Million
Q4 2021 Feb 10, 2022	BUY	$6.53 - $14.19 $334,727 - $727,379	51,260 Added 1.46%	3,563,435 $23.8 Million
Q3 2021 Nov 12, 2021	BUY	$8.25 - $41.0 $29 Million - $144 Million	3,512,175 New	3,512,175 $46.3 Million

5.49M

Ticker ZY
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 104,355,000
Market Cap $254M
Description
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to co...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.